TB-500 10mg for Sale USA — Research-Grade Healing Peptide (2026)

If you're building the Wolverine Stack, TB-500 is the half of the equation you cannot afford to get wrong. This synthetic peptide fragment of Thymosin Beta-4 is the primary driver of cell migration, new blood vessel formation, and tissue remodeling in the stack — and those properties are entirely dependent on getting genuine, research-grade product at the correct concentration.

The 10mg vial has become the standard research format for TB-500 because it provides the flexibility to run both loading and maintenance phases without constant reordering. But not every "10mg" vial on the market actually contains 10mg of active peptide. Some contain degraded product. Some are under-filled. Some never contained TB-500 at all.

This guide covers exactly where to source verified TB-500 10mg in the USA, what the research says about this peptide, how it fits into the Wolverine Stack protocol, and how to verify that what arrives at your door is actually what the label claims.

TB-500 Research Profile: What the Science Shows

TB-500 is a synthetic 43-amino-acid peptide corresponding to the active region (amino acids 17–23) of Thymosin Beta-4, a naturally occurring 4.9 kDa protein found in virtually all human cell types. The full molecule has a molecular weight of approximately 4963 Daltons, and the active fragment centers on the sequence LKKTETQ — the actin-binding domain responsible for most of TB-500's documented biological activity.

The primary mechanism of action is actin sequestration and upregulation. TB-500 binds to G-actin (monomeric actin) and promotes the formation of F-actin (filamentous actin), which is the structural protein that drives cell migration, cytoskeletal organization, and intracellular signaling. In practical terms, this means TB-500 increases the speed at which cells move toward an injury site.

Published research has documented several distinct biological effects:

• Angiogenesis — TB-500 promotes the formation of new blood vessels from existing vasculature. A 2010 study in the Journal of Investigative Dermatology demonstrated significantly accelerated wound closure and angiogenesis in treated models compared to controls, with new capillary networks forming up to 40% faster in treated tissues.
• Anti-inflammatory action — Research published in the Annals of the New York Academy of Sciences showed TB-500 downregulates inflammatory cytokines including IL-1β, TNF-α, and IL-6 at the injury site. This creates a more favorable environment for tissue repair rather than scar formation.
• Cardiac tissue repair — Multiple studies, including research from the National Academy of Sciences, have demonstrated TB-500's ability to reactivate progenitor cells in cardiac tissue after ischemic injury, promoting functional recovery of heart muscle that would otherwise form non-contractile scar tissue.
• Collagen deposition — TB-500 has been shown to influence the type and organization of collagen deposited during wound healing, favoring organized Type I collagen over the disordered Type III collagen typically seen in scar tissue.
• Hair follicle stem cell migration — Research has documented TB-500's role in activating hair follicle stem cells and promoting their migration to wound sites, where they contribute to tissue regeneration rather than scarring.

The peptide's unusually low molecular weight (4963 Da) gives it high systemic bioavailability following subcutaneous injection. Unlike many larger peptides that remain localized, TB-500 distributes widely through tissues — which is why it doesn't need to be injected at the specific injury site to produce effects. This systemic distribution is one of the properties that makes it particularly useful in research protocols targeting multiple tissue types simultaneously.

TB-500 in the Wolverine Stack: Why It Pairs with BPC-157

The Wolverine Stack isn't just two peptides thrown together. TB-500 and BPC-157 operate through fundamentally different — and complementary — biological pathways, which is what makes the combination more effective than either compound alone.

TB-500 handles the structural side. Its actin upregulation drives cell migration to the injury site, builds new blood vessel networks to supply those cells with oxygen and nutrients, and modulates collagen deposition for organized tissue repair. Think of it as the construction crew — it physically moves the materials into place and builds the infrastructure.

BPC-157 handles the signaling side. It activates nitric oxide (NO) pathways, upregulates growth factor receptors (VEGF, FGF, EGF), stabilizes the GI tract's repair mechanisms, and provides neuroprotective effects. BPC-157 is the project manager — it coordinates the biological signals that tell the construction crew where to go and what to build.

The synergy becomes clear when you look at the overlap points:

• Angiogenesis amplification — TB-500 physically builds new vessels while BPC-157 upregulates VEGF expression, meaning more vessels get built faster and with stronger signaling support.
• Dual anti-inflammatory pathways — TB-500 reduces cytokines at the tissue level while BPC-157 modulates the NO system and stabilizes mast cell activity. Two different braking mechanisms on the same inflammatory cascade.
• Migration + proliferation — TB-500 moves cells to the wound; BPC-157's growth factor upregulation causes those cells to proliferate faster once they arrive. The construction crew arrives quickly (TB-500) and then multiplies (BPC-157).
• Systemic + localized action — TB-500's low molecular weight gives it wide tissue distribution while BPC-157 has a documented affinity for GI tissue and tendons. Together, they cover both broad systemic repair and targeted tissue-specific healing.

This is why researchers running the Wolverine Stack typically report outcomes that exceed what either peptide produces individually. The two compounds aren't redundant — they're addressing different bottlenecks in the same repair process. For the full protocol breakdown, see the Wolverine Stack Dosage & Cycle Guide.

Sourcing TB-500 10mg in the USA: Vendor Comparison

We evaluated five US-based peptide suppliers on the criteria that matter for TB-500 specifically: verified purity documentation, accurate fill weights, shipping speed, and pricing for the standard 10mg research vial. Here's the current landscape as of April 2026.

Mini-Reviews

COA & Purity Verification: What to Check on Your TB-500 Certificate

A Certificate of Analysis is only useful if you know what you're looking at. Not all COAs are created equal, and some vendors publish documents that look official but contain incomplete or misleading information. Here's exactly what a legitimate TB-500 COA should include and how to read each component.

HPLC Purity Trace

High-Performance Liquid Chromatography (HPLC) is the primary method for determining peptide purity. On the COA, you're looking for a chromatogram showing a single dominant peak with minimal secondary peaks. The purity percentage should be listed explicitly — research-grade TB-500 should read 98% or higher, with top suppliers consistently hitting 99%+. Any COA that lists purity as a range ("95–99%") rather than a specific number is a yellow flag. Real testing produces a specific number.

Mass Spectrometry (MS) Confirmation

Mass spec tells you whether the molecule in the vial actually is TB-500. The COA should show a mass/charge (m/z) result consistent with the known molecular weight of TB-500: approximately 4963 Daltons. If the observed molecular weight is off by more than 1–2 Da, the product may be a different peptide entirely, a degraded fragment, or a mislabeled compound. This is the single most important line on the COA for verifying identity.

Endotoxin Testing

Endotoxins are bacterial byproducts that can contaminate peptide manufacturing. A proper COA will include a Limulus Amebocyte Lysate (LAL) test result showing endotoxin levels below 0.5 EU/mg. This is particularly important for injectable research peptides. If a COA omits endotoxin testing entirely, that's a significant gap in quality documentation — any serious manufacturer tests for this.

Reconstitution & Dosing Protocol

TB-500 ships as a lyophilized (freeze-dried) powder and must be reconstituted with bacteriostatic water before use. The process is straightforward, but getting the concentration math right is essential for accurate dosing throughout your research protocol.

Reconstitution Steps

1. Gather materials: TB-500 10mg vial, bacteriostatic water (BAC water containing 0.9% benzyl alcohol), alcohol swabs, and an insulin syringe (1ml, 29–31 gauge).
2. Swab tops: Clean the rubber stopper on both the TB-500 vial and the BAC water vial with alcohol swabs. Let dry for 10 seconds.
3. Draw BAC water: Using the syringe, draw 2ml of bacteriostatic water from the BAC water vial.
4. Add to peptide vial: Insert the needle through the rubber stopper of the TB-500 vial. Inject the BAC water slowly along the inside wall of the vial — do not spray directly onto the powder. The stream should run down the glass.
5. Swirl gently: Once the water is added, gently swirl the vial with a rolling motion between your fingers. Do not shake. The powder should dissolve completely within 30–60 seconds, producing a clear, colorless solution.
6. Store: Refrigerate at 2–8°C. Reconstituted TB-500 in BAC water is stable for approximately 25–30 days when refrigerated.

Concentration Math

With 10mg of TB-500 reconstituted in 2ml of BAC water:

• Concentration = 5mg/ml (10mg ÷ 2ml)
• Each 0.1ml (10 units on an insulin syringe) = 0.5mg
• For a 2.5mg dose, draw 0.5ml (50 units)

Research Dosing Protocols

Published research and documented protocols typically follow a two-phase structure:

Loading phase (weeks 1–4): 2.5mg administered twice weekly via subcutaneous injection. This equates to 5mg per week, or 20mg over the four-week loading period. For a Wolverine Stack protocol, TB-500 injections are typically administered on the same days as BPC-157.

Maintenance phase (weeks 5–8+): 2.5mg administered once weekly. This reduced frequency maintains circulating TB-500 levels while lowering total consumption. A full 8-week protocol at these doses requires approximately 35mg of TB-500, which translates to 3.5 vials of the 10mg format.

Subcutaneous Administration

TB-500 is typically administered via subcutaneous (SubQ) injection. Because of its systemic distribution properties, injection site selection is flexible — the peptide does not need to be administered at the injury location. Common injection sites include the lower abdominal fat pad (1–2 inches from the navel), the anterior thigh, and the back of the upper arm. Rotate injection sites between administrations to prevent tissue irritation.

Use a 29–31 gauge insulin syringe. Pinch a fold of skin at the injection site, insert the needle at a 45-degree angle, depress the plunger slowly, hold for 3–5 seconds, and withdraw. Apply light pressure with an alcohol swab if needed.

Safety Profile & Legal Status

TB-500 is classified as a research compound in the United States. It is not FDA-approved for therapeutic use in humans or animals, and it is not a controlled substance. Purchase and possession for research purposes is legal in all 50 states. No prescription is required.

It's worth noting that TB-500 (as Thymosin Beta-4) appears on the WADA prohibited list under Section S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics). This is relevant for any research context involving competitive athletics, but does not affect the compound's legal status for general research use.

The published safety data on TB-500 is limited primarily to animal models, where the compound has shown a favorable safety profile at standard research doses. No significant adverse effects have been documented in peer-reviewed literature at the dosing ranges commonly used in research protocols (2–5mg, 1–2 times weekly). The most commonly reported observations in anecdotal research logs include mild injection site redness (transient, resolving within hours), occasional headache during the initial loading phase, and temporary lethargy in the first few days of administration.

Frequently Asked Questions

Final Verdict: Where to Buy TB-500 10mg

For researchers building the Wolverine Stack or running TB-500 as a standalone compound, the sourcing decision comes down to verified quality and reliable delivery. Our top recommendation remains BioEdge Research for their combination of 99%+ verified purity, dual-method COA documentation, and the fastest domestic shipping in the category.

If you're already running the full Wolverine Stack, make sure your BPC-157 sourcing meets the same quality standards. Our complete peptide sourcing guide covers both compounds in detail, including the combo vial option that simplifies the protocol.